Monday, June 18, 2007

Labopharm's once-daily painkiller tramadol approved for sale in Canada

From CBC News:
Drug developer Labopharm Inc. (TSX:DDS) received some welcome relief of its own after Health Canada approved the sale of its once-daily painkiller tramadol despite ongoing concerns of U.S. regulators.

The health agency's therapeutic products directorate approved 100-milligram, 200-mg and 300-mg tablets of its formulation of tramadol for the management of moderate pain in adults who require treatment for several days or more, the Laval, Que.-based company said Monday.

"We're excited," Labopharm CEO James Howard-Tripp said in an interview.

"It's very positive for us. Canada is a smaller market than the U.S., but it's still a very important market. It's one of the G8, it's a very serious regulatory body, so it's nice to get approval from that perspective." ...more

No comments: